Citation: | PAN Liyan, JU Junliang, LI Yakan, GAO Huilong, MA Jinsheng, CHENG Miao. Effect of Tongxinluo Capsule on restenosis and serum inflammatory factors after carotid artery stenting[J]. Journal of Clinical Medicine in Practice, 2023, 27(8): 91-94, 100. DOI: 10.7619/jcmp.20230503 |
To explore the effects of Tongxinluo Capsule on restenosis and serum inflammatory factors after carotid artery stenting.
A total of 90 patients with carotid artery stenting were randomly divided into observation group and control group, with 45 cases in each group. Both groups were conducted with conventional treatment, while the observation group was given additional Tongxinluo Capsule for treatment. The levels of serum inflammatory factors [C reactive protein (CRP), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6)], vascular endothelial function indexes [vascular endothelial growth factor (VEGF), endothelin-1 (ET-1) and nitric oxide (NO)], hemodynamics indexes[carotid intima-media thickness (IMT), peak systolic blood flow velocity (SV), peak diastolic blood flow velocity (DV) and vascular resistance index (RI)], incidence of cardiocerebral vascular events, and the incidence of restenosis after carotid artery stenting were compared between two groups.
After half a year of treatment, the levels of CRP, TNF-α and IL-6 in the observation group were significantly lower than those in the control group (P < 0.05); the levels of VEGF and ET-1 in the observation group were significantly lower than those in the control group, while the level of NO was significantly higher than that in the control group (P < 0.05); the levels of IMT and RI in the observation group were significantly lower than those in the control group, while the levels of SV and DV were significantly higher than those in the control group (P < 0.05). The incidence of cardiocerebral vascular events in the observation group was 4.44%, which showed no significant difference when compared to 13.33% in the control group (P > 0.05). The incidence of postoperative restenosis in the observation group was 4.44%, which was significantly lower than 17.78% in the control group (P < 0.05).
The application of Tongxinluo Capsule after carotid artery stenting can delay the progression of atherosclerosis and reduce the degree of inflammatory reaction of patients, which is worthy of popularization and promotion.
[1] |
孟军鹏, 孟林. 颈动脉支架植入术对症状性颈动脉狭窄患者血清炎症因子及认知功能影响的临床研究[J]. 陕西医学杂志, 2020, 49(7): 796-799. doi: 10.3969/j.issn.1000-7377.2020.07.007
|
[2] |
李中中, 苏旭东, 刘琳, 等. 颈动脉支架置入术后支架内再狭窄研究进展[J]. 中国脑血管病杂志, 2021, 18(10): 733-736. doi: 10.3969/j.issn.1672-5921.2021.10.012
|
[3] |
高灵利, 李晓晖, 方建, 等. 注射用丹参多酚酸联合双联抗血小板药物对CYP2C19基因变异的颈动脉支架术后患者的治疗作用研究[J]. 药物评价研究, 2019, 42(2): 245-249.
|
[4] |
王丽娜, 张育磊, 黄可. 利伐沙班联合氯吡格雷在房颤病人颈动脉支架置入术后的应用[J]. 中国临床神经外科杂志, 2022, 27(10): 850-852. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGLC202210015.htm
|
[5] |
宋海玖, 田雅楠, 王光, 等. 通心络胶囊对冠脉支架植入术后患者血管内皮功能及相关炎性因子的影响[J]. 现代中西医结合杂志, 2021, 30(12): 1317-1320. doi: 10.3969/j.issn.1008-8849.2021.12.014
|
[6] |
周亮良. 通心络胶囊联合阿托伐他汀钙胶囊治疗颈动脉粥样硬化临床研究[J]. 新中医, 2019, 51(11): 89-92.
|
[7] |
赵越, 刘玉梅, 华扬, 等. 颈动脉重度粥样硬化性狭窄血管结构及血流动力学特征对临床缺血症状的预测分析[J]. 中国脑血管病杂志, 2020, 17(6): 285-290. doi: 10.3969/j.issn.1672-5921.2020.06.002
|
[8] |
刘晓纬, 徐学君, 陈科宇, 等. 颈动脉支架的特点及研究现状[J]. 中国微侵袭神经外科杂志, 2020, 25(4): 190-192. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWQX202004025.htm
|
[9] |
郭晓雷, 王玲玲, 肖志娇, 等. 降脂化栓方加减对颈动脉粥样硬化患者血脂、血管内皮功能及炎症因子的影响[J]. 现代中西医结合杂志, 2022, 31(8): 1067-1071. doi: 10.3969/j.issn.1008-8849.2022.08.009
|
[10] |
刘平, 崔公让. 不同程度颈动脉粥样硬化老年患者T淋巴细胞分化亚群、炎症水平与血管内皮功能关联性分析[J]. 免疫学杂志, 2020, 36(11): 976-983. https://www.cnki.com.cn/Article/CJFDTOTAL-MYXZ202011012.htm
|
[11] |
龙发青, 苏庆杰, 王德生, 等. 药物治疗联合支架置入对症状性颅内动脉粥样硬化性狭窄的疗效及短期预后评价[J]. 实用临床医药杂志, 2021, 25(17): 27-30, 47. doi: 10.7619/jcmp.20212248
|
[12] |
王丹, 方芳, 刘欣, 等. 通心络胶囊对颈动脉内膜中层厚度及外周血中性粒细胞/淋巴细胞比值的影响[J]. 中西医结合心脑血管病杂志, 2021, 19(7): 1156-1158.
|
[13] |
牟磊, 徐东成, 秦文玲, 等. 五虫通络胶囊防治颈动脉支架术后再狭窄的临床研究[J]. 中西医结合心脑血管病杂志, 2020, 18(9): 1371-1374.
|
[14] |
吴梦玮, 刘金民. 颈动脉粥样硬化836例患者中医体质分布特点[J]. 中华中医药杂志, 2022, 37(1): 353-357.
|
[15] |
王洁, 陈勇, 杨彤, 等. 通心络胶囊治疗颈动脉粥样硬化临床随机对照试验的Meta分析[J]. 中医临床研究, 2022, 14(15): 120-124. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYLY202215035.htm
|